These proteases include cell surface transmembrane protease/serine (TMPRSS) proteases, cathepsins , furin, elastase, factor Xa, and trypsin 70
At 26 weeks, the tesamorelin group showed roughly 15 to 18 percent reduction in visceral adipose tissue measured by CT versus placebo
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
Aggressive caloric restriction to shed accumulated fat inevitably results in some muscle loss